A collaborative approach to cancer research leads to more than $6 million in CPRIT funding for TAMHSC
The power of team science has landed Texas A&M Health Science Center more than $6.3 million in research funding to further study cancer treatment therapies. It comes at a crucial time in the U.S., as there are an estimated 1.6 million new cancer cases that will be diagnosed in 2015 alone, with nearly 600,000 cancer deaths.
Wielding Nature’s Sword: Researchers at Texas A&M discover new treatments against drug-resistant infections
Since World War II, antibiotics have been our only defense against bacterial infection, but overuse and misuse have caused some bacteria to develop resistance to antibiotics. Now, researchers at Texas A&M Health Science Center have discovered an entirely new class of antimicrobials that have the potential to kill drug-resistant bacteria.
Researchers are optimistic about new strategies to cure human ailments caused by fungal pathogens, thanks to a lab-engineered strain of simple baker’s yeast.